{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/cervical-cancer-hpv/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"6b2a8979-8ca9-5087-a80b-ea14445c034a","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field f2dc641f-b2b9-4ae6-8820-f1083b518f01 --><h2>Update</h2><!-- end field f2dc641f-b2b9-4ae6-8820-f1083b518f01 -->","summary":null,"htmlStringContent":"<!-- begin item 0f7c8eb0-eb5b-4f7d-b383-dcfa7aadec09 --><!-- end item 0f7c8eb0-eb5b-4f7d-b383-dcfa7aadec09 -->","topic":{"id":"38328a3b-8997-55f8-afac-19e980523812","topicId":"e2dafa6e-4749-48b2-b981-fa906c90d627","topicName":"Cervical cancer and HPV","slug":"cervical-cancer-hpv","lastRevised":"Last revised in September 2020","chapters":[{"id":"417b3c03-a940-5eb6-8b35-698036862be5","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"b4186a4a-8c1e-51ad-9743-d00be5b18f3d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"c2a58da0-8965-5522-8b3d-618890f730d3","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"2a436c60-1809-5f9f-bf39-409fd07e7af5","slug":"changes","fullItemName":"Changes"},{"id":"6b2a8979-8ca9-5087-a80b-ea14445c034a","slug":"update","fullItemName":"Update"}]},{"id":"c207e9ef-e492-5e67-8986-8b48ff76c55f","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"4e791e8f-015d-58bd-99ec-2689c4baa3e4","slug":"goals","fullItemName":"Goals"},{"id":"b04fb3a0-7363-5d87-b475-a7ad1e7ca9af","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"af911672-6dba-57d0-b3bf-4058c30f91ff","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"16911bc4-aa1d-56b2-aaf3-39695a5692f3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"9c781faa-cf3f-5dcc-b39d-4c10588cbbfb","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"713db7a4-b4c8-55f3-8ca0-e5c0db230466","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2f3819e7-a39a-5399-98a2-014b4d9243c2","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"e32e97af-cb99-5487-8ceb-1d8db9b2fe5f","slug":"types-of-cervical-cancer","fullItemName":"Types of cervical cancer"},{"id":"02013d86-5f8b-50e2-8bbc-9e9e5335f72d","slug":"causes","fullItemName":"Causes"},{"id":"961e80d0-b721-5756-b1df-56633ce9e5aa","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"4a62390f-59b9-5d3c-ad78-0394d8900138","slug":"prevalence","fullItemName":"Prevalence"},{"id":"5f216154-2a06-5aee-9270-f2388b590979","slug":"prognosis","fullItemName":"Prognosis"},{"id":"98782e4e-b481-5526-803b-b5f18e566c5d","slug":"complications","fullItemName":"Complications"}]},{"id":"0158af19-7ed5-56ac-a299-796dcf69f9a8","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"0a170049-907b-518b-9506-127d186d0a96","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"ae89986b-d468-50ca-b0d4-788dce1cc020","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"5aee8849-a5fc-592a-ba2f-161843f6a42e","slug":"cervical-cytology-sample","fullItemName":"Cervical cytology sample"},{"id":"8b13c601-cb6f-536e-a6cc-90001fa3357a","slug":"hpv-screening","fullItemName":"HPV screening"},{"id":"a05197b4-af3e-5fcb-9458-ec6446bb0cb9","slug":"referral","fullItemName":"Referral"}]},{"id":"75bee623-8a4b-5b31-b85b-b1f0cf45212d","fullItemName":"Management","slug":"management","subChapters":[{"id":"3918bf03-5c07-5c8f-bb28-5834e5dc1343","slug":"prevention","fullItemName":"Scenario: Prevention"},{"id":"5d0f88a0-5a31-5e1f-81ee-89cc202d9885","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"64ce0536-0d7d-554e-afc1-7859f158b82c","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"f4263e46-d3a8-5853-904f-7c0e9b926a1c","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"9b9af798-d073-5ea1-a174-157b46c68062","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"e827e587-3f77-5c14-92f8-58f34c105bbe","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"22b0924c-0e7d-5a46-b369-dd38ebbc4a39","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f012ac60-98ba-56b3-838a-7924e3544719","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"102ef6c4-0635-5f17-a33b-e2d83ec751b0","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1f31eeae-6068-5e2c-8097-3666754f067e","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"c2a58da0-8965-5522-8b3d-618890f730d3","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"aa70a5e8-a189-5cc9-93e4-439baebff3d8","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field ca7cd63e-e970-488b-a678-c8bdd8f4b33b --><h3>New evidence</h3><!-- end field ca7cd63e-e970-488b-a678-c8bdd8f4b33b -->","summary":null,"htmlStringContent":"<!-- begin item 36bf4980-984f-4cc0-897a-44f0746610ad --><!-- begin field b16de9a9-9d65-4ff8-9374-4292958eac9e --><h3>Evidence-based guidelines</h3><!-- end field b16de9a9-9d65-4ff8-9374-4292958eac9e --><!-- begin field 8673052c-a18a-4cd8-99cf-96f36d64e22c --><p>PH (2018) <em>HPV vaccination for MSM: guidance for health professionals</em>. Public Health England. <a href=\"https://www.gov.uk/\" data-hyperlink-id=\"c59b9f5e-4cb6-448a-ab16-a98f0046e2fd\">www.gov.uk</a> [<a href=\"https://www.gov.uk/government/publications/hpv-vaccination-for-msm-guidance-for-health-professionals\" data-hyperlink-id=\"644f061b-0bd3-4887-8037-a98f0046e316\">Free Full-text</a>]</p><!-- end field 8673052c-a18a-4cd8-99cf-96f36d64e22c --><!-- begin field bc4f2b4c-3e8c-45a6-a48f-1e2222145d90 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field bc4f2b4c-3e8c-45a6-a48f-1e2222145d90 --><!-- begin field 57c7e93c-7662-4477-8342-06a6a56df329 --><p>No new HTAs since 1 April 2017.</p><!-- end field 57c7e93c-7662-4477-8342-06a6a56df329 --><!-- begin field 65e43096-9e7a-4d1c-b961-ed3f2ada3bb9 --><h3>Economic appraisals</h3><!-- end field 65e43096-9e7a-4d1c-b961-ed3f2ada3bb9 --><!-- begin field c0d7fd0b-7f6e-4f0f-812b-c16b87dcbf85 --><p>No new economic appraisals since 1 April 2017.</p><!-- end field c0d7fd0b-7f6e-4f0f-812b-c16b87dcbf85 --><!-- begin field e55b9a54-1514-4197-9d7d-525fe37709d2 --><h3>Systematic reviews and meta-analyses</h3><!-- end field e55b9a54-1514-4197-9d7d-525fe37709d2 --><!-- begin field 7e564069-c0d1-488c-afa3-773d8d61eff6 --><p>No new systematic reviews or meta-analyses since 1 April 2017.</p><!-- end field 7e564069-c0d1-488c-afa3-773d8d61eff6 --><!-- begin field 464f2bd0-1982-4abd-aa76-f7b12f8faf9e --><h3>Primary evidence</h3><!-- end field 464f2bd0-1982-4abd-aa76-f7b12f8faf9e --><!-- begin field 664b30ff-6e42-4433-a323-e1c4e3264a13 --><ul><li>Lei, J., Ploner, A., Elfstrom, M., et al. (2020) <em>HPV vaccination and the risk of invasive cervical cancer. </em>New England Journal of Medicine. <a href=\"https://www.nejm.org/\" data-hyperlink-id=\"c6de40eb-e136-48bb-b3c6-ac4800ae19c9\">www.nejm.org</a> [<a href=\"https://www.nejm.org/doi/full/10.1056/NEJMoa1917338\" data-hyperlink-id=\"7022a5f3-97e6-486c-98a7-ac4800ae1a9a\">Abstract</a>]</li></ul><!-- end field 664b30ff-6e42-4433-a323-e1c4e3264a13 --><!-- end item 36bf4980-984f-4cc0-897a-44f0746610ad -->","subChapters":[]},{"id":"6a0d9a6c-816e-576b-9270-09b8a7230b3e","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field e17e3234-7631-4f40-b7a1-a149c206254b --><h3>New policies</h3><!-- end field e17e3234-7631-4f40-b7a1-a149c206254b -->","summary":null,"htmlStringContent":"<!-- begin item 7335d1ca-a64a-4831-8795-4c8617713835 --><!-- begin field 5561c020-8099-4de8-b92e-da0431abeac8 --><p>No new national policies or guidelines since 1 April 2017.</p><!-- end field 5561c020-8099-4de8-b92e-da0431abeac8 --><!-- end item 7335d1ca-a64a-4831-8795-4c8617713835 -->","subChapters":[]},{"id":"c1be6d9e-151c-5cd1-90e9-87059bd6bf8c","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field f77327e4-9b83-4c69-84c9-06abe7d011aa --><h3>New safety alerts</h3><!-- end field f77327e4-9b83-4c69-84c9-06abe7d011aa -->","summary":null,"htmlStringContent":"<!-- begin item bf97d9c7-3380-4df1-b0d7-187a29230001 --><!-- begin field f26b6409-b6d5-4359-9ee8-9715cb779f34 --><p>No new safety alerts since 1 April 2017.</p><!-- end field f26b6409-b6d5-4359-9ee8-9715cb779f34 --><!-- end item bf97d9c7-3380-4df1-b0d7-187a29230001 -->","subChapters":[]},{"id":"387c95e6-906e-58bc-99c7-6110ad9ae5d6","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 85fbf25c-a324-4aa9-a3e0-bb0dc3964ec7 --><h3>Changes in product availability</h3><!-- end field 85fbf25c-a324-4aa9-a3e0-bb0dc3964ec7 -->","summary":null,"htmlStringContent":"<!-- begin item c0513d98-16fa-42bf-a2eb-0cec62efedbc --><!-- begin field 5a6f51dc-bda9-4bd1-917f-62e52e47ab29 --><p>No changes in product availability since 1 April 2017.</p><!-- end field 5a6f51dc-bda9-4bd1-917f-62e52e47ab29 --><!-- end item c0513d98-16fa-42bf-a2eb-0cec62efedbc -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}